Physician

Daniel E Ross, D.O.

According to 2025 Medicare claims, Daniel Ross, D.O. (NPI: 1528037256) practices neurology in the Pensacola-Ferry Pass-Brent, FL market, with the plurality of this provider's patient population coming from Escambia, FL. This provider's primary affiliated billing organization is EMERALD COAST CENTER FOR NEUROLOGICAL DISORDERS (NPI: 1750315701; TIN: 204625991) and primary practice location at 32504-8649.

Ross' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,584 traditional Medicare patients, billed 62,543 HCPCS/CPT codes, and received $730,916 in Medicare payments. The top billing code was 95910 (Nerve conduction, 7-8 studies). Part D data shows 6,615 prescription claims across 862 beneficiaries totaling $3,166,610 in drug costs, led by Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50). DME data shows 4,204 claims. Open Payments data shows 266 records totaling $5,659. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $406,865 to $730,916. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,481,694 to $3,166,610. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $70,536 to $166,328.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,248	15,583	$406,865
2016	1,234	24,625	$460,942
2017	1,295	27,945	$504,852
2018	1,340	29,400	$481,485
2019	1,299	34,412	$563,633
2020	1,237	37,702	$503,993
2021	1,319	39,354	$557,229
2022	1,376	46,874	$578,273
2023	1,491	54,526	$656,861
2024	1,584	62,543	$730,916

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	478	4,705	$1,481,694
2016	514	4,740	$1,775,682
2017	509	4,893	$1,532,406
2018	536	5,239	$1,716,147
2019	561	5,200	$1,818,864
2020	583	5,473	$2,228,537
2021	643	5,949	$2,719,769
2022	684	5,779	$2,946,333
2023	736	5,953	$3,235,699
2024	862	6,615	$3,166,610

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	480	990	$68,758
2016	851	1,647	$70,805
2017	1,274	2,945	$97,325
2018	1,607	3,524	$117,646
2019	1,808	4,058	$130,237
2020	2,015	4,368	$172,077
2021	1,948	4,361	$170,940
2022	2,124	4,794	$198,280
2023	1,933	4,397	$209,750
2024	1,999	4,204	$155,681

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95910	Nerve conduction, 7-8 studies	187	187	$129
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	298	439	$127
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	498	713	$87
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	305	652	$71
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	239	258	$62

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	49	1,204	$585,905
Panzyga	Immun Glob G(Igg)-Ifas/Glycine	18	378	$241,695
Nurtec Odt	Rimegepant Sulfate	96	2,960	$159,460
Nuplazid	Pimavanserin Tartrate	22	780	$131,140
Emgality Pen	Galcanezumab-Gnlm	133	5,206	$120,053

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7032	Cushion for use on nasal mask interface, replacement only, each	N	112	250	$21,557
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	192	413	$19,877
A7030	Full face mask used with positive airway pressure device, each	N	110	252	$19,550
E0601	Continuous positive airway pressure (cpap) device	Y	101	522	$16,867
A7031	Face mask interface, replacement for full face mask, each	N	107	244	$15,974

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	266	$5,659	MDD US Operations, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel E. Ross, D.O.?

Tedicare shows public-source Medicare data for Daniel E. Ross, D.O. (NPI 1528037256), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel E. Ross, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel E. Ross, D.O.?

Daniel E. Ross, D.O. is linked to EMERALD COAST CENTER FOR NEUROLOGICAL DISORDERS (billing NPI 1750315701) in the available physician profile data.

Does Daniel E. Ross, D.O. have Open Payments data?

Daniel E. Ross, D.O. has 266 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.